Dr. Aya Haggiagi
Claim this profileColumbia University Medical Center
Studies Mesial Temporal Sclerosis
Studies Brain Tumor
3 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Aya Haggiagi is currently running
Lenalidomide + Nivolumab
for Lymphoma
This trial tests a combination of drugs to treat a rare brain cancer. The treatment aims to starve the tumor, boost the immune system, and stop cancer cells from growing. It targets patients with primary CNS lymphoma who may not respond well to standard treatments.
Recruiting1 award Phase 119 criteria
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3
More about Aya Haggiagi
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Aya Haggiagi has experience with
- Nivolumab
- ONC201
- Lenalidomide
- Rituximab
- Methotrexate
- Ipilimumab
Breakdown of trials Aya Haggiagi has run
Mesial Temporal Sclerosis
Brain Tumor
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aya Haggiagi specialize in?
Aya Haggiagi focuses on Mesial Temporal Sclerosis and Brain Tumor. In particular, much of their work with Mesial Temporal Sclerosis has involved H3 K27M positive patients, or patients who are undergoing treatment.
Is Aya Haggiagi currently recruiting for clinical trials?
Yes, Aya Haggiagi is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Aya Haggiagi has studied deeply?
Yes, Aya Haggiagi has studied treatments such as Nivolumab, ONC201, Lenalidomide.
What is the best way to schedule an appointment with Aya Haggiagi?
Apply for one of the trials that Aya Haggiagi is conducting.
What is the office address of Aya Haggiagi?
The office of Aya Haggiagi is located at: Columbia University Medical Center, New York, New York 10032 United States. This is the address for their practice at the Columbia University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.